We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIL icon
1051
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$82K 0.01%
+900
New +$82.3K
EAF icon
1052
GrafTech
EAF
$212M
$82K 0.01%
699
-526
-43% -$66.1K
NWBI icon
1053
Northwest Bancshares
NWBI
$2.28B
$82K 0.01%
4,937
+3,429
+227% +$57.3K
RY icon
1054
Royal Bank of Canada
RY
$293B
$82K 0.01%
1,046
-28,944
-97% -$2.33M
TER icon
1055
Teradyne
TER
$59.3B
$82K 0.01%
1,201
-1,146
-49% -$72.8K
MRTX
1056
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$82K 0.01%
640
-798
-55% -$77K
SNP
1057
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$82K 0.01%
1,360
-3,131
-70% -$182K
ENTG icon
1058
Entegris
ENTG
$23.2B
$81K 0.01%
1,623
-767
-32% -$37K
ESPR
1059
DELISTED
Esperion Therapeutics
ESPR
$81K 0.01%
1,361
+238
+21% +$10.7K
OVV icon
1060
Ovintiv
OVV
$16.4B
$81K 0.01%
3,479
-10,836
-76% -$232K
RHI icon
1061
Robert Half
RHI
$4.37B
$81K 0.01%
1,275
-2,554
-67% -$148K
VLUE icon
1062
iShares MSCI USA Value Factor ETF
VLUE
$9.44B
$81K 0.01%
898
-427
-32% -$36.6K
CEQP
1063
DELISTED
Crestwood Equity Partners LP
CEQP
$81K 0.01%
+2,638
New +$86.8K
UNVR
1064
DELISTED
Univar Solutions Inc.
UNVR
$81K 0.01%
3,332
-2,015
-38% -$45.6K
IPGP icon
1065
IPG Photonics
IPGP
$3.84B
$80K 0.01%
551
-964
-64% -$134K
NOK icon
1066
Nokia
NOK
$52.3B
$80K 0.01%
21,506
-4,645
-18% -$18.3K
TBPH icon
1067
Theravance Biopharma
TBPH
$877M
$80K 0.01%
3,094
+1,296
+72% +$25.2K
ABB
1068
DELISTED
ABB Ltd
ABB
$80K 0.01%
3,341
+255
+8% +$5.46K
MIME
1069
DELISTED
Mimecast Limited
MIME
$80K 0.01%
1,842
-2,813
-60% -$117K
ADEA icon
1070
Adeia
ADEA
$3.11B
$79K 0.01%
16,231
+10,833
+201% +$57.5K
ARGX icon
1071
argenx
ARGX
$54.1B
$79K 0.01%
495
+173
+54% +$23.4K
BB icon
1072
BlackBerry
BB
$5.26B
$79K 0.01%
12,412
-47,560
-79% -$261K
EXPE icon
1073
Expedia Group
EXPE
$37.3B
$79K 0.01%
732
-2,103
-74% -$247K
G icon
1074
Genpact
G
$5.81B
$79K 0.01%
1,882
+792
+73% +$31.6K
OVID icon
1075
Ovid Therapeutics
OVID
$491M
$79K 0.01%
+19,063
New +$60.2K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.